(R)-Ziftomenib ((R)-KO-539) is the R-enantiomer of Ziftomenib ( HY-132001 ). Ziftomenib (KO-539) is an orally active menin-MLL interaction inhibitor with antitumor activities.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Epigenetic Reader Domain
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。